Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Ribomic Inc.
No Price
Closing Price XTKS 28.04.2026:
79,00 JPY
28.04.2026 06:30
Current Prices from Ribomic Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
4591.T
JPY
28.04.2026 06:30
79,00 JPY
-1,00 JPY
-1,25 %
Share Float & Liquidity
Free Float99,57 %
Shares Float51,37 M
Shares Outstanding51,59 M
Company Profile for Ribomic Inc. Share
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.
